Li Zhang, MD, PhD

Daiichi Sankyo
East Amherst, NY, United States

Daiichi Sankyo Inc.

Presentation(s):

• 2349: Selection of the Dose for Subcutaneous Administration to Non-Japanese Subjects and Intravenous Administration to Japanese Subjects in the First-in-Human Study of DS-7011a, an Anti-TLR7 Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.